Recent trends in cardiovascular complications among men and women with and without diabetes

Diabetes Care

Volumn 29, Issue 1, 2006, Pages 32-37

  Booth, Gillian L ^a,b,c   Kapral, Moira K ^a,c,d   Fung, Kinwah ^c   Tu, Jack V ^a,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; STROKE; TREND STUDY; CANADA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; FACTUAL DATABASE; MIDDLE AGED;

ADULT; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ONTARIO; RETROSPECTIVE STUDIES;

EID: 33644875549     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.01.06.dc05-0776     Document Type: Article

References (35)

1. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KMV: The evolving diabetes burden in the United States. Ann Intern Med 140:945-950, 2004
2. Haffner S, Lehto S, Onnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
3. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE: The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow up. Arch Intern Med 161:1717-1723, 2001
4. Manuel DG, Schultz SE: Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Diabetes Care 27:407-414, 2004
5. Thomas RJ, Palumbo PJ, Melton LJ III, Roger VL, Ransom J, O'Brien PC, Leibson CL: Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, MN, 1970-1994. Arch Intern Med 163:445-451, 2003
6. Gillum RF: Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 23:1273-1277, 1994
7. Stamler J: The marked decline in coronary heart disease mortality rates in the United States, 1968-1981: summary of findings and possible explanations. Cardiology 72:11-22, 1985
8. McGovern PC, Pankow JS, Shahar E, Dolixzny KM, Folsom AR, Blackburn H, Luepker RV, the Minnesota Heart Survey Investigators: Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 334:884-890, 1996
9. Rosamund WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang C-H, Heiss G: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.N Engl J Med 339:861-867, 1998
10. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297, 1999
11. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB, Wilson PWF, Savage PJ: Trends in cardiovascular complications of diabetes. JAMA 292:2495-2499, 2004
12. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512-516, 2002
13. Tu JV, Naylor CD, Austin P: Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 161:1257-1261, 1999
14. Naylor CD, Chen E: Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 24:1431-1438, 1994
15. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293:1868-1874, 2005
16. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D: Trends in the prevalence of hypertension, antihypertensive therapy and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 340:1221-1227, 1999
17. Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, et al.: Prevalence of high blood cholesterol among US adults: an update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 269:3009-3014, 1993
18. National Center for Health Statistics, Centers for Disease Control and Prevention: Cigarette smoking among adults: United States, 1990. MMWR Morb Mortal Wkly Rep 41:354-362, 1992
19. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
20. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000
21. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22, 2002
22. Shah B, Mamdani M, Kopp A: Drug use in older people with diabetes. In Diabetes in Ontario: An ICES Practice Atlas. Hux JE, Booth GL, Slaughter PM, Laupacis A, Eds. Toronto, Canada, Institute for Clinical Evaluative Sciences, 2003, p. 51-76. Available from http://www.ices.on.ca/file/DM_Chapter3.pdf. Accessed 15 September 2003
23. Kamalesh M, Subramanian U, Ariana A, Sawada S, Tierney W: Similar decline in post-myocardial infarction mortality among subjects with and without diabetes. Am J Med Sci 329:228-233, 2005
24. Alter DA, Khaykin Y, Austin PC, Tu JV, Hux JE: Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: do physicians under-treat? Diabetes Care 26:1427-1434, 2003
25. Norhammar A, Malmberghttp K, Rydén L, Tornvall T, Stenestrand U, Wallentin L, the Register of Information and Knowledge about Swedish Heart Intensive Care, Admissions (RIKS-HIA): Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24:838-844, 2003
26. Brophy JM, Diodati JG, Bogaty P, Theroux P: The delay to thrombolysis: an analysis of hospital and patient characteristics: Quebec Acute Coronary Care Working Group. CMAJ 158:475-480, 1998
27. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI: Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 283:3223-3229, 2000
28. Hackam DG, Tan MK, Honos GN, Leiter LA, Langer A, Goodman SG, the Vascular Protection registry investigators: How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry. Am Heart J 148:1028-1033, 2004
29. Ko DT, Mamdami M, Alter DA: Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291:1864-1870, 2004
30. Tran CT, Laupacis A, Mamdani MM, Tu JV: Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 148:834-841, 2004
31. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Cheng SC, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel F: Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 156:799-805, 1996
32. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145-153, 2000
33. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81-106, 1994
34. National Center for Disease Prevention and Health Promotion: Diabetes surveillance, 1999. Chapter 5: Cardiovascular disease [article online]. Available from http://www.cdc.gov/diabetes/statistics/cvdhosp/ihd/fig3.htm. Accessed 15 December 2003
35. Hall RE, Tu JV, the Canadian Cardiovascular Outcomes Research Team: Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999. Can J Cardiol 19:1123-1131, 2003